Provided by Tiger Trade Technology Pte. Ltd.

GRAND PHARMA

5.150
+0.0500.98%
Volume:5.68M
Turnover:29.36M
Market Cap:18.28B
PE:14.53
High:5.290
Open:5.070
Low:5.070
Close:5.100
52wk High:9.559
52wk Low:4.530
Shares:3.55B
HK Float Shares:3.55B
Volume Ratio:0.76
T/O Rate:0.16%
Dividend:0.17
Dividend Rate:3.28%
EPS(LYR):0.354
ROE:7.38%
ROA:4.23%
PB:1.07
PE(LYR):14.53
PS:1.49

Loading ...

Grand Pharma's Partner Telix Advances Global First-in-Class Radiopharmaceutical TLX591-Tx for Prostate Cancer Treatment

Stock News
·
Jul 03

Grand Pharma: June 2026 Monthly Return Shows No Share Capital Changes, Public Float Maintained

Bulletin Express
·
Jul 02

Grand Pharmaceutical Group - Enters Huadong Medicine Supply Agreement on June 8, 2026

THOMSON REUTERS
·
Jun 08

Grand Pharmaceutical - Under Deal, Grand Pharm (China) to Supply Pharmaceutical Preparations, Raw Materials, Others to Huadong Medicine, Others

THOMSON REUTERS
·
Jun 08

Grand Pharma's Nuclear Medicine Partner Showcases Key Product at ASCO, Groundbreaking RDC Drug Data Reinforces Global Competitiveness

Stock News
·
Jun 07

Grand Pharma AGM Greenlights All Resolutions; Final Dividend Set at HK$0.169 Per Share

Bulletin Express
·
Jun 05

Grand Pharma Adopts Comprehensive Bye-Law Overhaul Ahead of 2026 AGM

Bulletin Express
·
Jun 05

Grand Pharmaceutical Group shareholders approve HK$ 0.169 final dividend proposal

Reuters
·
Jun 05

GRAND PHARMA's Nuclear Medicine Partner Telix Achieves Key Milestone in Overseas Phase I Study for Novel Product TLX101 in Newly Diagnosed Glioblastoma

Stock News
·
May 21

Grand Pharma’s April 2026 HKEX Filing Shows No Change to 3.55 Billion Issued Shares, Public Float Remains Compliant

Bulletin Express
·
May 04

国控医药2025年营收稳步增长,核医学与重症治疗创新布局多项成果

Bulletin Express
·
Apr 29

Grand Pharma: 2025 Revenue Rises to HK$12.28 Billion, R&D Spend Hits HK$1.46 Billion and Dividend Totals HK$600 Million

Bulletin Express
·
Apr 29

Grand Pharma Plans Bye-Law Overhaul to Meet HKEX Paperless, Treasury Share Requirements

Bulletin Express
·
Apr 29

Grand Pharma Sets 5 June 2026 AGM; Proposes HK$0.169 Final Dividend and New Share Mandates

Bulletin Express
·
Apr 29

Grand Pharmaceutical Group Releases 2025 Annual Report and Shifts to Full Electronic Dissemination

Bulletin Express
·
Apr 29

Grand Pharma Tables 20% Issuance Mandate, HK$0.169 Dividend Ahead of 5 June AGM

Bulletin Express
·
Apr 29

Grand Pharma Sets 5 June 2026 AGM; Proposes HK$0.169 Final Dividend, Director Re-elections and Bye-law Update

Bulletin Express
·
Apr 29

Grand Pharmaceutical proposes adopting new bye-laws to align with paperless listing regime

Reuters
·
Apr 29

Grand Pharma releases 2025 ESG report

Reuters
·
Apr 29

Grand Pharmaceutical publishes 2025 annual report

Reuters
·
Apr 29